Anna-friederike Marx
Basel, BS 4009, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Chronic infection perturbs the affinity hierarchy of antiviral B cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 31, 2026
Non-cytolytic re-engineering of a viral vaccine vector enables durable effector-memory T cell immunity by reinforcing type I IFN induction.
Journal: Molecular therapy. Nucleic acids
Published: November 24, 2025
Orf virus-based vectors induce potent germinal center B cell, Tfh cell, and CD8+ T cell responses.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 13, 2025
Durable lymphocyte subset elimination upon a single dose of AAV-delivered depletion antibody dissects immune control of chronic viral infection.
Journal: Immunity
Published: June 19, 2024
Central tolerance shapes the neutralizing B cell repertoire against a persisting virus in its natural host.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 06, 2024
A type 1 immunity-restricted promoter of the IL-33 receptor gene directs antiviral T-cell responses.
A type 1 immunity-restricted promoter of the IL-33 receptor gene directs antiviral T-cell responses.
Journal: Nature immunology
Published: January 24, 2023
Vaccine-elicited CD4 T cells prevent the deletion of antiviral B cells in chronic infection.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 29, 2021
Vectored antibody gene delivery restores host B and T cell control of persistent viral infection.
Journal: Cell reports
Published: April 29, 2021
Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack.
Journal: Cell reports. Medicine
Published: September 15, 2020
Last Updated: 09/26/2026